EGFR and systemic sclerosis: In particular, EGFR+ SSc fibroblasts expressed higher levels of genes associated with Wnt signaling (SFRP2, CTHRC1, and WISP2), a pathway activated by fibroblasts that mostly reside in the reticular dermis (13) and is hyperactivated in SSc skin (30).